Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial

NCT04414189 is registered in ClinicalTrials.gov with Inflammatix as lead sponsor.

NCT NCT04414189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04414189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Validation of HostDx Sepsis™ on NanoString; a Prospective Observational Validation Trial
Lead sponsor
Inflammatix
Phase
Observational
Overall status
Completed
Start date
June 7, 2020
Completion date
October 19, 2021
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis